ZA928159B - N-Phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property. - Google Patents

N-Phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property.

Info

Publication number
ZA928159B
ZA928159B ZA928159A ZA928159A ZA928159B ZA 928159 B ZA928159 B ZA 928159B ZA 928159 A ZA928159 A ZA 928159A ZA 928159 A ZA928159 A ZA 928159A ZA 928159 B ZA928159 B ZA 928159B
Authority
ZA
South Africa
Prior art keywords
cyano
phenyl
pharmaceuticals
alkyl
hydroxycrotonamide
Prior art date
Application number
ZA928159A
Other languages
English (en)
Inventor
Rudolf Schleyerbach
Robert Ryder Bartlett
Elizabeth Anne Kuo
Edward James Little
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA928159B publication Critical patent/ZA928159B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/27—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA928159A 1991-10-23 1992-10-22 N-Phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property. ZA928159B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4134934 1991-10-23

Publications (1)

Publication Number Publication Date
ZA928159B true ZA928159B (en) 1993-08-04

Family

ID=6443223

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA928159A ZA928159B (en) 1991-10-23 1992-10-22 N-Phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property.

Country Status (23)

Country Link
US (2) US5747664A (ja)
EP (1) EP0538783B1 (ja)
JP (1) JP3119738B2 (ja)
KR (1) KR930007443A (ja)
CN (1) CN1071833A (ja)
AT (1) ATE128353T1 (ja)
AU (1) AU658679B2 (ja)
BR (1) BR9204124A (ja)
CA (1) CA2081173A1 (ja)
CZ (1) CZ281693B6 (ja)
DE (1) DE59203828D1 (ja)
DK (1) DK0538783T3 (ja)
ES (1) ES2079765T3 (ja)
FI (1) FI924779A (ja)
GR (1) GR3017751T3 (ja)
HU (1) HUT63610A (ja)
IL (1) IL103487A (ja)
MX (1) MX9206082A (ja)
NO (1) NO178922C (ja)
NZ (1) NZ244814A (ja)
RU (1) RU2090553C1 (ja)
SK (1) SK319892A3 (ja)
ZA (1) ZA928159B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
DE4127737A1 (de) 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
WO1994024095A1 (en) * 1993-04-16 1994-10-27 Abbott Laboratories Immunosuppressive agents
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
US5624946A (en) * 1994-07-05 1997-04-29 Williams; James Use of leflunomide to control and reverse chronic allograft rejection
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19547648A1 (de) * 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
DE19702988A1 (de) * 1997-01-28 1998-07-30 Hoechst Ag Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika
US6303652B1 (en) 1998-08-21 2001-10-16 Hughes Institute BTK inhibitors and methods for their identification and use
US6355678B1 (en) * 1998-06-29 2002-03-12 Parker Hughes Institute Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
DE19857009A1 (de) * 1998-12-10 2000-06-15 Aventis Pharma Gmbh Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren
DE102005017592A1 (de) * 2005-04-16 2006-10-19 Lindner, Jürgen, Dr. med. Darreichungsformen und Kombinationspräparate von Pyrimidinbiosyntheseinhibitoren zur Erzielung zusätzlicher Wirkungen auf das Immunsystem
US20160287549A1 (en) 2013-11-22 2016-10-06 Genzyme Corporation Novel methods for treating neurodegenerative diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2555789A1 (de) * 1975-12-11 1977-07-07 Hoechst Ag Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
JPH0776202B2 (ja) * 1985-07-01 1995-08-16 三井東圧化学株式会社 アシルアミノブテニルニトリル誘導体、その製造法およびそれらを含有する除草剤および農園芸用殺菌剤
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
DE69002792T2 (de) * 1989-05-09 1993-12-09 Sds Biotech Corp Crotonsäureamidderivate und sie enthaltende Insektizide.
DD297328A5 (de) * 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5034410A (en) * 1989-10-11 1991-07-23 Syntex (U.S.A.) Inc. Anthelmintically active benzenepropanamide derivatives
IL99811A (en) * 1990-10-30 1996-03-31 Roussel Uclaf 3-Cycloalkyl-propanamides, tautomeric forms of these, their salts, method of preparation, use as drugs and preparations containing them

Also Published As

Publication number Publication date
IL103487A (en) 1998-01-04
CA2081173A1 (en) 1993-04-24
DK0538783T3 (da) 1996-02-05
NZ244814A (en) 1994-06-27
CZ319892A3 (en) 1993-05-12
JP3119738B2 (ja) 2000-12-25
CZ281693B6 (cs) 1996-12-11
IL103487A0 (en) 1993-03-15
US5773470A (en) 1998-06-30
BR9204124A (pt) 1993-06-01
MX9206082A (es) 1993-07-01
EP0538783A1 (de) 1993-04-28
HU9203327D0 (en) 1992-12-28
AU658679B2 (en) 1995-04-27
EP0538783B1 (de) 1995-09-27
FI924779A (fi) 1993-04-24
NO178922B (no) 1996-03-25
KR930007443A (ko) 1993-05-20
US5747664A (en) 1998-05-05
JPH05201948A (ja) 1993-08-10
GR3017751T3 (en) 1996-01-31
HUT63610A (en) 1993-09-28
NO924093L (no) 1993-04-26
FI924779A0 (fi) 1992-10-21
ES2079765T3 (es) 1996-01-16
ATE128353T1 (de) 1995-10-15
RU2090553C1 (ru) 1997-09-20
CN1071833A (zh) 1993-05-12
NO178922C (no) 1996-07-03
NO924093D0 (no) 1992-10-22
DE59203828D1 (de) 1995-11-02
AU2721592A (en) 1993-04-29
SK319892A3 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
IL103487A0 (en) N-phenyl-2-cyano-3-hydroxycrotonamide derivatives and their use as pharmaceuticals having an immunomodulatory property
FI912998A (fi) Foerfarande foer framstaellning av aralifatiskt n-substituerade aminoalkanfosfinsyror.
ZA918126B (en) Di(aromatic)compounds and their use in human and veterinary medicine and in cosmetics
PH25571A (en) Alpha'-alkyl-4-amino-3-quinolinemethanols, 1-(4-aralkylamino-3-quinolinyl) alaknones, their use as medicaments
ATE8050T1 (de) N-(4-aminobenzoyl)-n'-benzylbispidin, seine herstellung und dieses enthaltende arzneimittel.
DE59200773D1 (de) Arzneimittel zur Behandlung von Abstossungsreaktionen bei Organverpflanzungen.
DE69024778D1 (de) 2-Aminopyrimidin-4-carboxamid-Derivate, deren Herstellung und deren therapeutische Anwendung
DK0572635T3 (da) Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
ATE173252T1 (de) Arylmorpholine, herstellung und verwendung
EP0481299A3 (en) N-phenyl-piperidyl-4-amines and drugs containing them
IL107454A0 (en) Pharmaceutical compositions containing imidazol-1-yl compounds
ATE131819T1 (de) 2-hydroxy-3-phenoxy-propyl-substituierte piperazine, ihre herstellung und verwendung
DK0628039T3 (da) 2,3,4,5-tetrahydro-1H-benzazepiner og farmaceutisk acceptable syreadditionssalte deraf.
PT78155B (de) N-(3-trifluormethylphenyl)-n'-propargylpiperazin seine herstellung und verwendung
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.